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Abstract 
There is limited information about wildland firefighters’ exposure to polycyclic aromatic 
hydrocarbons (PAHs), being scarce studies that included the impact of tobacco consumption. Thus, 
this work evaluated the individual and cumulative impacts of firefighting activities and smoking on 
wildland firefighters’ total exposure to PAHs. Six urinary PAH metabolites (1-hydroxynaphthalene 
(1OHNaph), 1-hydroxyacenaphthene (1OHAce), 2-hydroxyfluorene (2OHFlu), 1-
hydroxyphenanthrene (1OHPhen), 1-hydroxypyrene (1OHPy), and 3-hydroxybenzo[a]pyrene 
(3OHB[a]P)) were quantified by high-performance liquid chromatography with fluorescence 
detection. Firefighters from three fire stations were characterized and organized in three groups: non-
smoking and non-exposed to fire emissions (NSNExp), smoking non-exposed (SNExp), and 
smoking exposed (SExp) individuals. 1OHNaph + 1OHAce were the most predominant OH-PAHs 
(66–91% ∑OH-PAHs), followed by 2OHFlu (2.8–28%), 1OHPhen (1.3–7%), and 1OHPy (1.4–6%). 
3OHB[a]P, the carcinogenicity PAH biomarker, was not detected. Regular consumption of tobacco 
increased 76–412% ∑OH-PAHs. Fire combat activities promoted significant increments of 158–
551% ∑OH-PAHs. 2OHFlu was the most affected compound by firefighting activities (111–1068%), 
while 1OHNaph + 1OHAce presented the more pronounced increments due to tobacco 
consumption (22–339%); 1OHPhen (76–176%) and 1OHPy (20–220%) were the least influenced 
ones. OH-PAH levels of SExp firefighters were significantly higher than in other groups, suggesting 
that these subjects may be more vulnerable to develop and/or aggravate diseases related with PAHs 
exposure. 
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1. Introduction 
Human biomonitoring allows assessment of total personal exposure, including environmental and 
workplace hazardous chemicals, through the analysis of chemicals and/or their metabolites in human 
exhaled air, blood, urine, milk, saliva, nails, hair, faeces, and adipose tissue [1], [2]. Among the many 
human matrices, urine is by far the most common one [3], [4], [5]. Thus the use of human 
biomonitoring is a precious tool as it estimates the total internal dose regardless of the source, route, 
and duration of the exposure. 
 
Occupational exposure of firefighters, i.e. firefighters directly involved in firefighting activities, was 
classified as a possible carcinogen to humans by the International Agency for Research on Cancer 
(IARC group 2B; [6]) and the US National Institute for Occupational Safety and Health (NIOSH; 
[7]). Wildland firefighters are frequently exposed to numerous pollutants (particulate matter, carbon 
monoxide, nitrogen dioxide, volatile organic compounds including polycyclic aromatic hydrocarbons 
(PAHs), polybrominated diphenyl ethers, polychlorinated dibenzo-p-dioxin, etc.) that are released 
during fires [5], [8], [9], [10], [11], [12], [13]. Exposure to wildfire smoke is being associated with 
respiratory morbidity with growing evidence supporting an association with all-cause mortality, being 
consistently related with cardiovascular effects, specific causes of mortality, birth outcomes, and 
mental health disorders [14]. 
 
Tobacco consumption is an additional risk factor for potential health effects, since prolonged 
exposure to tobacco smoke is, by itself, the major cause of lung cancer [15]. Tobacco smoke is a 
complex mixture of thousands of chemical substances including over 69 known carcinogens; 
therefore, tobacco smoking and its exposure are classified as known human carcinogens by most of 
the international agencies [15], [16]. 
 
In terms of the main constituents isolated from the mainstream smoke of cigarettes and air emissions 
released during wildland and agricultural fires, PAHs are a relevant group of compounds that cause 
carcinogenic effects [15]. PAHs are ubiquitous pollutants that are included in the lists of priority 
pollutants of the European Union [17] and US Environmental Protection Agency [18] due to their 
mutagenic and carcinogenic properties [19], [20], [21]. They are formed during incomplete 
combustion of organic matter and originate from both natural and anthropogenic sources [22], [23]. 
Human exposure to PAHs occurs by all routes of exposure, namely inhalation, ingestion, and skin 
contact [8], [24], [25], [26], [27], [28]. Once absorbed into blood stream, PAHs are biotransformed 
and distributed within human body, being mostly eliminated through urine as glucuronide and/or 
sulfate conjugates [22], [29], [30]. Thus, urinary metabolites of PAHs (OH-PAHs) reflect a more 
accurate estimation of the total exposure. Urinary 1-hydroxypyrene (1OHPy), the major metabolite 
of pyrene, is the most frequently used biomarker to assess PAHs exposure [1], [11], [31], [32], [33]. 
3-hydroxybenzo[a]pyrene (3OHB[a]P) is one of the metabolites of benzo[a]pyrene, and it is 
considered as the PAH biomarker of carcinogenicity [32]. 1-hydroxynaphthalene (1OHNaph) is 
frequently used to assess the exposure to naphthalene [34], a PAH that was selected as an important 
indicator of indoor air pollution by the World Health Organization (WHO) [35]. Due to the ubiquity 
of PAHs, their various sources and routes of exposure, the use of more than one PAHs biomarker 
better characterizes the total exposure of a subject. 
 
Despite the undeniable role that firefighters play in maintaining population safety, limited 
information related with their occupational exposure to PAHs is available in the literature [4], [5], 
[11], [31], [33], [34], [36], [37], [38], being scarce studies that included the impact of tobacco 
consumption [34], [37]. Moreover, biomonitoring of wildland firefighter’s exposure to PAHs from 
fire emissions has been mostly performed during training exercises [11], [34], [37], [38] and typically 
based exclusively on 1OHPy analysis [31], [33], [37], [38]. Exposure to PAHs has been associated 
with the development and/or aggravation of lung function reduction, specifically with exacerbations 
of asthma and chronic obstructive pulmonary disease, some cardiovascular pathologies and cancer 
[39], [40], [41]. Excess morbidity and mortality in firefighters have been related with those diseases 
and some selected site-specific cancers comparatively with general population [42], [43], [44], [45], 
[46], [47]. 
 
Thus, the present study aims to characterize the impact of tobacco consumption and occupational 
exposure on wildland firefighters’ total exposure to PAHs. Six urinary PAH metabolites (1OHNaph, 
1-hydroxyacenaphthene (1OHAce), 2-hydroxyfluorene (2OHFlu), 1-hydroxyphenanthrene 
(1OHPhen), 1OHPy and 3OHB[a]P) were determined in three different groups of subjects: i) non-
smoking non-exposed firefighters (NSNExp) who were not involved in firefighting activities within 
the previous week of urine sampling, ii) smoking firefighters who were not exposed to any kind of 
fire emissions (SNExp), and iii) smoking exposed firefighters (SExp) who actively participated in 
wildland fire combat activities (knockdown and/or overhaul) within the 48 h prior the urine 
collection. Comparison between the urinary levels of individual and total OH-PAHs among the three 
groups was conducted in order to evaluate the individual and cumulative impacts of the tobacco 
consumption and participation in firefighting activities on wildland firefighters’ total exposure to 
PAHs. 
 
2. Materials and methods 
2.1. Characterization of the study population 
A total of 108 healthy firefighters serving at three different fire stations, namely Vinhais (VNH), 
Mirandela (MDL) and Bragança (BRG) participated in this study. Fire stations were situated in Trás-
os-Montes and Alto Douro Region, the Northeast area of the country that is every year strongly 
affected by wildfires [48]. This geographical area is characterized by very hot and dry summers, and 
cold winters. All firefighters of the selected fire stations were requested to fill a structured 
questionnaire, which was adapted from a validated form [49]. The questionnaire was used to collect 
firefighters’ personal information on age, weight, number of years of occupational exposure as 
firefighters, time dedicated to firefighting activities in the last 48 h and the use of personal protective 
equipment during that period; exposure to environmental tobacco smoke, tobacco smoking habits 
(including the number of cigarettes smoked per day for smokers), and the most frequently consumed 
meals (boiled, roasted, and grilled) during the week before urine collection. Also, some clinical 
parameters, such as cardiac frequency, individual diastolic and systolic blood pressure (Geratherm 
Desktop, Geratherm Medical AG, Geschwenda, Germany), and the arterial oxygen saturation (Oxy-
100 pulse oximeter, Gima, Italy) were measured in each participant at the end of the work shift. Body 
mass index (BMI; kg/m2) was determined for each fireman. According to the information collected 
through the questionnaires, firefighters were organized into three different groups: NSNExp, SNexp 
and Sexp. The protocol was reviewed and approved by the Ethic Committee of University of Porto, 
Portugal (Project Ethics Committee No. 12/CEUP/2015) and all participants gave a written 
informed consent. 
 
2.2. Urine sampling, extraction and chromatographic analysis 
Collection campaigns were performed at the three fire stations during June to September 2015. All 
firefighters were asked to collect a spot urine sample at the end of a regular work shift between 
Tuesday and Thursday in order to avoid the impact of different personal weekend activities. Urine 
samples were collected in sterilized 50 mL polycarbonate containers and frozen at −20 °C until 
analysis. 
 
Extraction and chromatographic analysis of urinary OH-PAHs were done according to Oliveira et 
al. [5] and Chetiyanukornkul et al. [50]. Calibration curves were prepared with OH-PAH mixed 
standards in methanol except for 1OHNaph and/or 1OHAce that were quantified with a matrix-
matched calibration curve; they presented good correlation coefficients (6 calibration points; R2 ≥ 
0.9979). The methodology was validated by recovery experiments with values ranging from 70.0 to 
117.5%. Detection limits varied between 0.0008 μg/L urine for 2OHFlu to 0.195 μg/L urine for 
1OHNaph + 1OHAce with respective quantification limits ranging from 0.0028 to 0.650 μg/L urine. 
Intra and inter-precision assays were performed during six consecutive days with RSD values ranging 
from 1.3% (2OHFlu) to 6.4% (1OHPhen) and between 1.3% to 8.1% (1OHNaph + 1OHAce, and 
1OHPy), respectively [5]. Representative chromatograms are exhibited in Fig. 1S (Supplementary 
material). 
 
Urinary creatinine levels (μmol/mol) were quantified according to the Jaff colorimetric method [51] 
and used to normalize the urinary concentrations of OH-PAHs. 
 
All determinations were performed in triplicate. 
 
2.3. Statistical treatment 
Statistical analysis was performed using SPSS (IBM SPSS Statistics 20) and Statistica (v. 7, StatSoft 
Inc., USA) software. Median values of individual and ΣOH-PAHs were compared through the 
nonparametric Mann–Whitney U test since normal distribution was not observed by Shapiro-Wilk’s 
test. Statistical significance was defined as p ≤ 0.05. 
 
3. Results and discussion 
3.1. Characterization of the study population 
The overall mean ages were 34 years for NSNExp (22–48 years) and SNExp (21–60 years) 
firefighters, while SExp subjects had a mean age of 31 years (21–53 years); no statistical difference (p 
> 0.05) was observed between the three groups. 
 
BMI, the most commonly used index of weight-for-height, is a tool commonly used to classify 
underweight (<18.5 kg/m2), normal weight (18.5–25 kg/m2), overweight (25–30 kg/m2), and 
obesity (degree I: 30–35 kg/m2; degree II: 35–40 kg/m2; degree III: ≥40 kg/m2) in adults [52]. The 
overall BMI values ranged between 19 kg/m2 (SNExp of VNH and SExp of MDL) to 36 kg/m2 
(NSNExp of BRG) (mean 25 kg/m2) (Table 1). A total of 61% of firefighters had normal BMI 
values; 22% of NSNExp, 3% of SNExp, and 14% of SExp individuals presented BMI values higher 
than 25 kg/m2, suggesting an overweight. Significant differences of BMI levels were observed 
between NSNExp (28 kg/m2) and SNExp (24 kg/m2; p = 0.05) groups, and among NSNExp and 
SExp subjects (24 kg/m2; p = 0.013). NSNExp firefighters serving at MDL and BRG fire 
corporations had mean BMI levels indicative of overweight, with some individuals revealing values 
of degree I and II of obesity [52] (Table 1). Obesity is a nutritional pathology that may conduct to 
the development of health problems [52]. The determined BMI levels are in accordance with the 
national report, which indicated that 52.8% of the Portuguese adult population was overweight in 
2014 [53].
  
Arterial hypertension is an asymptomatic disease characterized by continually elevated blood 
pressure, usually diastolic blood pressure ≥90 mmHg and/or systolic blood pressure ≥140 mmHg 
[54]. The values of diastolic and systolic blood pressure in firefighters ranged between 49 and 114 
and 120–152 mmHg for NSNExp, 61–97 and 108–152 mmHg for SNExp and from 60 to 98 and 
113–156 mmHg for SExp subjects, respectively. A total of 83% of NSNExp and SNExp, and 61% 
of SExp firefighters presented normal values of blood pressure; 17% (NSNExp and SNExp) to 39% 
(SExp) of the participants revealed to have levels higher than the recommended limits (Table 1). The 
cardiac frequency observed in firefighters was overall within the recommended range of 60–100 heart 
beats/min [55]. The arterial oxygen saturation values were also within the normal range of 95–100% 
[55]. 
 
 
 
3.2. Detection rates of OH-PAHs 
The detection of urinary OH-PAHs confirms the exposure to PAHs, regardless of the source. The 
collection of spot urine samples in occupational biomonitoring studies is frequently used, however 
the variability in the volume of urine collected and its total water content needs to be taken into 
consideration. To overcome these limitations, the creatinine adjustment is the most frequently used 
method to normalize the concentrations of urinary metabolites [56], thus it was applied in this study. 
Creatinine can be also used as a criterion of acceptability of the collected spot urine samples if its 
concentrations range between 0.3 g/L to 3.0 g/L [57]. In this study, urinary creatinine concentrations 
varied from 0.706 to 2.90 g/L for NSNExp individuals, between 0.91 to 2.77 g/L for SNExp firemen, 
and 0.700 to 2.95 for SExp subjects. No significant differences were found between the groups (p > 
0.05). 1OHPhen was quantified in all samples, 1OHNaph + 1OHAce, 2OHFlu, and 1OHPy were 
determined in 97% of the urine samples. 3OHB[a]P was never detected and thus it was excluded 
from the further analysis. Some authors have observed that PAHs with low molecular weight (2 and 
3 aromatic rings, such as naphthalene, acenaphthene, fluorene, and phenanthrene) are predominantly 
eliminated as macromolecules conjugates through the urine [4], [5], [23], [58], [59]. Information 
related with pharmacokinetics of OH-PAHs is very scarce, reason why the elimination kinetics of 
PAH metabolites for each route of exposure remain unclear. For 1OHPy, the most characterized 
OH-PAH, the half-life excretion rate varies between 6 and 35 h [60], [61], from 4.4–12 h [58], [62] 
and up to 13 h [62], [63], [64] after inhalation, ingestion, and dermal exposures, respectively. For the 
other OH-PAHs, Li et al. [59] reported a half-life excretion rate of 3.3–6.2 h for 1OHNaph, 2.3–4.0 
h for 2OHFlu, and 4.3–6.1 h for 1OHPhen for ingestion in non-smoking volunteers with no 
occupational exposure to PAHs. With increasing molecular weight of PAHs, the complexity of their 
metabolism also increases so metabolites of high molecular weight PAHs are predominantly 
eliminated through the feces rather than in urine [59], [65]. Fernando et al. [34] detected 1OHPy and 
3-hydroxyfluoranthene in less than 50% of the total samples. Other authors have also reported very 
low detection rates for 3OHB[a]P in exposed (smoking and non-smoking) workers [59], [66], [67]. 
 
 
 
  
3.3. Impact of tobacco smoke 
The concentrations of individual compounds in NSNExp and SNExp groups, organized per fire 
station, are presented in Fig. 1. The levels of 1OHNaph + 1OHAce (0.033–0.98 μmol/mol 
creatinine; 0.138–4.19 μg/L urine), 1OHPhen (0.002–0.077 μmol/mol creatinine; 0.007–0.362 μg/L 
urine), and 1OHPy (0.004–0.089 μmol/mol creatinine; 0.022–0.369 μg/L urine) (Fig. 1) determined 
in this study for NSNExp individuals were well below the reference values defined by the German 
Human Biomonitoring Commission for the general non-smoking population: <30 μg/L urine for 
1OHNaph [68], 0.6 μg/L urine for 1OHPhen and 0.5 μg/L urine for 1OHPy [68], [69], [70]. The 
levels were in a similar range as those reported by Haines et al. [71] for the Canadian population 
during the third cycle (2012–2013) of a large ongoing study (2007–2019) conducted by the Canadian 
Health Measure Surveys, and also in agreement with the concentrations previously reported for other 
NSNExp Portuguese firefighters [4]. In European countries, the consumption of any kind of tobacco 
was restricted and/or forbidden in enclosed public places, on public transport and in workplaces, 
with only limited exceptions allowed for some particular economic sectors [72]. Thus firefighters 
considered in this study were not exposed to environmental tobacco smoke in the facilities of the 
respective fire stations. Non-smoking firefighters also reported in their questionnaire that they were 
not exposed to environmental tobacco smoke outside of their fire corporation in the week preceding 
the urine collections. The quantification of urinary cotinine, the principal metabolite of nicotine 
(biomarker of exposure to tobacco smoke) allows validating data (obtained by the questionnaires) 
concerning the smoking habits of firefighters; however, it was not determined in this study. Still, there 
is generally a high concordance level between the information reported in the questionnaires of 
smoking industrial workers and the urinary concentrations of cotinine [73], being the differences 
observed between NSNExp and SNExp firefighters attributed to tobacco consumption. Also, it 
should be taken in consideration that the studied individuals reported diets exclusive of charbroiled 
and deep-fried foods within the five days before urine collection, so the contribution of food to the 
overall PAHs exposure can be considered as negligible. 
 
Fig. 1. Concentrations of urinary monohydroxyl-PAHs (median, 25–75 percentiles and range; μmol/mol creatinine; 
1OHNaph + 1OHAce: 1-hydroxynaphthalene and 1-hydroxyacenaphthene; 2OHFlu: 2-hydroxyfluorene; 1OHPhen: 1-
hydroxyphenanthrene; 1OHPy: 1-hydroxypyrene) determined in non-smoking non-exposed (NSNExp) and in smoking 
non-exposed (SNExp) firefighters’ from three different fire stations (Vinhais (VNH), Mirandela (MDL), and Bragança 
(BRG)). *Statistically significant differences at p ≤ 0.05 between non-smoking non-exposed and smoking non-exposed 
firefighters (non-parametric Mann–Whitney U test). The value of LOD/√2 was used whenever the concentration of OH-
PAHs was below the LOD [90]. 
 
 
Levels of total OH-PAHs (∑OH-PAHs) in Portuguese firefighters are exhibited in Table 2. At the 
three fire stations, the median concentrations of individual (Fig. 1) and total (Table 2) compounds in 
SNExp were overall higher than in NSNExp subjects. Urinary concentrations of 1OHNaph + 
1OHAce for SNExp firefighters were increased from 22% (VNH: 0.097 versus 1.18 μmol/mol 
creatinine; p > 0.05) to 339% (MDL: 0.67 versus 2.96 μmol/mol creatinine; p = 0.024) comparatively 
with NSNExp individuals. The urinary levels of the other PAH metabolites followed the same 
tendency: 29% (BRG: 0.017 versus 0.022 μmol/mol creatinine; p > 0.05) to 188% (VNH: 0.118 
versus 0.340 μmol/mol creatinine; p = 0.009) for 2OHFlu, 76% (VNH: 0.029 versus 0.051 μmol/mol 
creatinine; p = 0.002) to 176% (MDL: 0.074 versus 0.204 μmol/mol creatinine; p > 0.05) for 
1OHPhen, and 20% (VNH: 0.020 versus 0.024 μmol/mol creatinine; p > 0.05) to 167% (BRG: 0.009 
versus 0.024 μmol/mol creatinine; p = 0.005) for 1OHPy (Fig. 1). Feunekes et al. [37] also found 
concentrations of 1OHPy that were 213% higher in the urine of smokers compared with non-
smoking firefighters (0.47 versus 0.15 μmol/mol creatinine; p = 0.01) during a set of controlled fires 
in a confined training area. Overall, tobacco consumption promoted a ∑OH-PAHs concentration 
increase of 76% (BRG) to 412% (VNH) (Table 2). In agreement, Fernando et al. [34] previously 
reported higher levels of urinary OH-PAHs for smoking firefighters during training exercises at 
Canadian burn houses. In addition, the majority of available studies (mostly non-occupational ones) 
also concluded that smokers possess higher levels of urinary OH-PAHs than non-smoking subjects 
[74], [75], which may be attributed to the occurrence of genetic polymorphisms in the carcinogen 
metabolizing enzymes [15], [74]. Benzo[a]pyrene, the only known human carcinogenic PAH [17] has 
been detected in cigarette smoke only in small quantities and therefore it is difficult to detect its 
metabolites in the urine of smoking people [15], [61]. Haines et al. [71] detected benzo[a]pyrene, 
chrysene, and fluoranthene metabolites in less than 2% of the urine samples collected in Canadian 
citizens within the Canadian Health Measures Survey during the third cycle of the study. No 
significant differences were observed between the distribution profiles of OH-PAHs in NSNExp 
and SNExp subjects, with 1OHNaph + 1OHAce accounting for 66–91% of ∑OH-PAHs, followed 
by 2OHFlu (4.9–21%), 1OHPhen (1.8–6.9%), and 1OHPy (1.5–6.3%) (Fig. 2a and b). Still, Lu and 
Zhu [76] described a similar profile for 17 airborne PAHs in the tobacco smoke of 12 commercial 
brand cigarettes (2–3 aromatic rings accounted with 74% of ΣPAHs; 4-ring compounds represented 
11% of ΣPAHs and PAHs with 5 and more aromatic rings contributed with 15% of ΣPAHs). 
 
 
 
 
 
Fig. 2. Distribution of monohydroxyl-PAHs (1OHNaph + 1OHAce: 1-hydroxynaphthalene and 1-hydroxyacenaphthene; 
2OHFlu: 2-hydroxyfluorene; 1OHPhen: 1-hydroxyphenanthrene; 1OHPy: 1-hydroxypyrene) in the urine of non-smoking 
non-exposed firefighters (a), smoking non-exposed (b) and smoking exposed (c) firefighters from different fire stations 
(Vinhais (VNH), Mirandela (MDL), and Bragança (BRG)). 
 
The relation between the urinary levels of individual and total OH-PAHs with the number of smoked 
cigarettes for each SNExp subject was explored through the determination of Spearman correlation 
coefficients (r). The attained correlations were predominantly medium to high (r ≥ 0.878 and p ≤ 
0.021 at BRG; r ≥ 0.603 and p ≤ 0.205 at VNH; r = 0.878 and p ≤ 0.021 at MDL, except for 
1OHNaph + 1OHAce and 2OHFlu at VNH and MDL fire corporations). Hagedorn et al. [74] also 
observed significant correlations (r = 0.34–0.63 and p < 0.001) between the levels of urinary OH-
PAHs with the daily cigarette consumption in smokers, revealing that smokers of cigarettes with 
higher tar yield excreted significantly higher amounts of urinary 1- and 2OHNaph, 2OHFlu, 1 + 
9OHPhen, 2 + 3OHPhen, and 1OHPy than non-smokers. 
 3.4. Impact of fire emissions 
Since no significant differences were observed between the number of cigarettes consumed by 
SNExp and SExp firefighters (p > 0.05), these two groups were used to study the influence of fire 
emissions on firefighter’s ΣPAHs exposure. Fig. 3 presents the median concentrations of each OH-
PAH and the respective ranges for SNExp and SExp firefighters per station, while the respective 
distribution (%) is exhibited in Fig. 2(b and c). Firemen who were directly involved in wildland fire 
combats reported the use of self-protective equipment with flame-retardant properties, helmet with 
eye protection, flashhood and gloves, as required by the Portuguese legislation [77]. However, the 
urinary median concentrations of individual (Fig. 3) and ∑OH-PAHs (Table 2) was overall higher in 
SExp than in SNExp firefighters. 1OHNaph + 1OHAce were by far the most predominant OH-
PAHs, accounting for 72–91% and 66–84% of ∑OH-PAHs for (smoking) non-exposed and exposed 
subjects, respectively (Fig. 2b and c). Their concentrations increased between 48% (MDL: 2.96 versus 
4.38 μmol/mol creatinine) and 268% (VNH: 1.18 versus 4.35 μmol/mol creatinine) for SExp 
firefighters compared with SNExp subjects (p ≤ 0.024; Fig. 3). 2OHFlu was the second most 
abundant PAH metabolite (2.8–21% of ∑OH-PAHs for SNExp and 13–28% for SExp firefighters), 
followed by 1OHPy (1.5–4.2% versus 1.4–3.1%) and 1OHPhen (1.3–3.4% versus 1.6–2.6%). Urinary 
2OHFlu was the compound with the highest increment in SExp individuals, increasing from 111% 
(VNH: 0.340 versus 0.718 μmol/mol creatinine; p = 0.031) to 1068% (BRG: 0.022 versus 0.257 
μmol/mol creatinine; p ≤ 0.001) while 1OHPy (83% (BRG: 0.044 versus 0.024 μmol/mol creatinine, 
p = 0.001) to 220% (MDL: 0.462 versus 0.144 μmol/mol creatinine, p > 0.05)) and 1OHPhen were 
the least affected (87% (BRG: 0.016 versus 0.030 μmol/mol creatinine; p = 0.005) to 112% (VNH: 
0.051 versus 0.108 μmol/mol creatinine; p > 0.05)) by firefighters’s exposure to emissions released 
during firefighting activities (Fig. 3). These findings are in accordance with the small but significant 
increase of 1OHPy concentrations determined in the urine of 13 individuals at a firefighting training 
school [38]. Edelman et al. [36] reported urinary 1-, 2-, and 3OHPhen and 1OHPy increments ranging 
from 22 to 61% and 76 to 81% in firemen who actively participated in firefighting activities during 
and after the World Trade Center collapse. Laitinen et al. [11] also observed urinary 1OHPy 
concentrations that were 50–537% higher in European firefighting trainers at gas and fire house 
diving simulators. More recently, Fernando et al. [34] found significantly elevated concentrations (up 
to 40-fold increase when compared with the baseline, 0.6 μg/g of creatinine) of total post exposure 
urinary 1- and 2OHNaph, 2-, 3-, and 9OHFlu, and 2-, 3-, and 4OHPhen in 25 firefighters during 
training exercises at Canadian burn houses; similar trend was also reported by Oliveira et al. [5] for 
non-smoking firefighters that were directly involved in fire combat (knockdown and overhaul). BRG 
was the fire station where the differences between SNExp and SExp individuals were all statistically 
significant for individual (Fig. 3c) and total (Table 2) OH-PAHs (p ≤ 0.05). Within the SExp 
firefighters serving at BRG fire corporation, three individuals presented much higher levels of 
1OHNaph + 1OHAce (49.6–52.2 μmol/mol creatinine) in comparison with the other exposed 
colleagues; no specific source was identified to justify these higher levels. The median ∑OH-PAH 
concentrations ranged between 0.74 (BRG) and 2.06 μmol/mol creatinine (MDL) for SNExp and 
from 1.91 (BRG) to 5.71 μmol/mol creatinine (MDL) for SExp (Table 2). The determined levels of 
∑OH-PAHs increased between 158 (BRG) and 551% (VNH) (p ≤ 0.02) in exposed firemen, 
reflecting the impact of firefighting activities on the total PAHs exposure (Table 2). 
~ 
 
Fig. 3. Concentrations of urinary monohydroxyl-PAHs (median, 25–75 percentiles and range; μmol/mol creatinine; 
1OHNaph + 1OHAce: 1-hydroxynaphthalene and 1-hydroxyacenaphthene; 2OHFlu: 2-hydroxyfluorene; 1OHPhen: 1-
hydroxyphenanthrene; 1OHPy: 1-hydroxypyrene) determined in smoking non-exposed (SNExp) and smoking exposed 
(SExp) firefighters’ from three different fire stations (Vinhais (VNH), Mirandela (MDL), and Bragança (BRG)). 
*Statistically significant differences at p ≤ 0.05 between smoking non-exposed and smoking exposed firefighters (non-
parametric Mann–Whitney U test). The value of LOD/√2 was used whenever the concentration of OH-PAHs was below 
the LOD [90]. 
 
The inter-relation between individual and total OH-PAHs was also estimated. Overall, moderate to 
strong correlations were observed among individual compounds and between individual OH-PAHs 
with ∑OH-PAHs for SExp individuals working at VNH (r ≥ 0.737; p ≤ 0.006, except between 
1OHPhen with 1OHNaph + 1OHAce and with ∑OH-PAHs) and BRG (r ≥ 0.514; p ≤ 0.050, except 
between 2OHFlu and 1OHNaph + 1OHAce and with 1OHPy) fire stations. These findings indicated 
the predominant impact of common sources of PAHs exposure. In addition, the correlation between 
the urinary levels of individual and ΣOH-PAHs with the number of hours that each firefighter 
dedicated to combat activities were also estimated. In general, moderate to strong correlations were 
observed for all firefighters from the characterized fire stations: r ≥ 0.760 and p ≤ 0.028 at VNH; r 
≥ 0.878 and p ≤ 0.021 except for 2OHFlu and 1OHPhen at MDL; r ≥ 0.413 and p ≤ 0.023 except 
for 1OHNaph + 1OHAce and 1OHPy at BRG. These results show the influence of participation in 
fire combat activities on ΣPAHs exposure of firemen. Despite the short period of exposure, the use 
of self-protective equipment revealed to be insufficient to protect firemen from the emissions 
released during fires and thus preventive action measures should be implemented to reduce inhalation 
and dermal exposure to PAHs during fire combat. 
 
In a view of the scarce information regarding firefighters’ occupational exposure, comparison with 
the reported results is extremely difficult. Furthermore, the reported data are frequently not 
normalized with creatinine concentrations [11], [33], [36]. Still, the urinary levels of 1OHPy in SExp 
firefighters (overall range: 0.025 μmol/mol creatinine at VNH to 0.462 μmol/mol creatinine at MDL) 
were lower than those reported for 43 Canadian firefighters involved in a fire combat (0.080–3.63 
μmol/mol creatinine; [31]). The concentrations in SExp firefighters determined in this study were 
overall higher than the levels observed for NSNExp firefighters serving at other Portuguese fire 
stations [5]. 
 
Limited information is available concerning the reference standards and guidelines for urinary levels 
of OH-PAHs. In 2010, the American Conference of Governmental Industrial Hygienists 
recommended a 1OHPy limit of 0.5 μmol/mol creatinine for occupational PAHs exposure [78]. Only 
three exposed firefighters from MDL fire station exceeded that reference guideline, the urinary OH-
PAH concentrations of those firemen being much lower than the no-biological effect limit of 1.4 
μmol/mol creatinine proposed by Jongeneelen [29]. 
 
3.5. Cumulative effects of tobacco smoke and fire emissions 
The majority of occupational health effects, including the development of cancers, are predominantly 
caused by exposure to a multiple causal factors rather than to a specific agent; as a consequence, 
people exposed to more than one risk factor are more prompt to present the symptoms and develop 
the illness. Smoking firefighters are simultaneously exposed to the potential health effects of tobacco 
consumption and the hazardous fire emissions. In comparison with NSNExp firefighters, the urinary 
concentrations of ∑OH-PAHs in SExp individuals increased from 355% (BRG: 1.91 versus 0.42 
μmol/mol creatinine; p ≤ 0.001) to 3237% (VNH: 5.34 versus 0.16 μmol/mol creatinine; p ≤ 0.001) 
(Table 2). The median urinary concentrations of individual compounds were augmented as high as 
308% (BRG: 0.394 μmol/mol creatinine in NSNExp subjects versus 1.61 μmol/mol creatinine in 
SExp; p ≤ 0.001) to 550% (MDL: 0.674 versus 4.38 μmol/mol creatinine; p = 0.002) for 1OHNaph 
+ 1OHAce, from 508% (VNH: 0.118 versus 0.718 μmol/mol creatinine; p ≤ 0.001) to 1412% (BRG: 
0.017 versus 0.257 μmol/mol creatinine; p ≤ 0.001) for 2OHFlu, and from 97% (MDL: 0.074 versus 
0.146 μmol/mol creatinine; p = 0.009) to 275% (BRG: 0.008 versus 0.030 μmol/mol creatinine; p ≤ 
0.001) for 1OHPhen. Urinary 1OHPy presented a similar trend with increments ranging between 
25% (VNH: 0.020 versus 0.025; p > 0.05) to 579% (MDL: 0.068 versus 0.462 μmol/mol creatinine; 
p ≤ 0.001). The increments in the urinary levels of OH-PAHs reflect the potential cumulative effects 
of smoking consumption and occupational activities to the total PAHs exposure. In general, urinary 
2OHFlu and 1OHNaph + 1OHAce were the most affected compounds by the impact of both 
factors. The Bartlett sphericity test showed that these metabolites were strongly correlated with each 
other (r = 0.600; p < 0.001). Principal component analysis (PCA) was performed based on urinary 
concentrations of those two OH-PAHs for NSNExp, SNExp, and SExp firefighters (Fig. 2S, 
Supplementary material). The Kaiser–Meyer–Olkin values were ≥0.5 for both variables. The first 
function (F1) issued from PCA explained up to 80.01% of the total variance, presenting the highest 
loadings for both variables (square cosines values >0.800). It allowed the differentiation of the 
majority of SExp and NSNEXP firefighters from the others, highlighting the discriminating power 
of urinary 1OHNaph + 1OHAce and 2OHFlu. The second function (F2) contributed with 19.99% 
of the original data. NSNEXP subjects are grouped together with mostly negative F1 and (or near 
zero) F2 scores. Still, a higher number of subjects would be precious to corroborate the findings 
achieved in this study. 
 
Previously, Feunekes et al. [37] also found significant influences of both tobacco smoking and 
exposure to smoke released during fires on the urinary levels of 1OHPy in trainers and instructors 
from a firefighting school. More recently, Fernando et al. [34] observed higher levels of urinary OH-
PAHs and methoxyphenols in smoking firefighters compared with non-smoking subjects working at 
four Canadian fire stations during training exercises at burn houses. The concentrations of urinary 
OH-PAHs in Portuguese SExp firefighters were mainly much lower than the levels reported for other 
relevant occupations concerning PAHs exposure, such as coke-oven workers, iron foundry and 
aluminum production workers, mining workers, as well as employees from graphite electrodes, 
refractory materials, and special carbon products industrial productions [67], [73], [79], [80]. 
 
Little information is available concerning the impact of short- and long-term exposure to fire 
emissions in firefighters’ health. It has been reported that cardiovascular disease is the leading cause 
of excess morbidity and mortality in firefighters [9], [42], [43]. Some investigators have notice a higher 
incidence of respiratory and pulmonary symptoms as well as airways hyper-responsiveness and decay 
in lung function of firefighters during fire combat activities [9], [81], [82]. In addition, tobacco smoke 
is associated with the development of lung cancer among other types of cancers and diseases, namely 
leukemia and cancers of the urinary and aerodigestive tracts as well as of stomach, pancreas, liver, 
breast, prostate, and colorectal tissues [15]. Some authors have also described an increased risk of 
developing respiratory, inflammatory and cardiovascular illnesses in smokers [83], [84], [85]. Thus 
SExp firefighters are more vulnerable to the development and/or aggravation of cardio-respiratory 
diseases; cumulative and synergistic effects may occur. Certain life styles may also potentiate the 
health risks associated with firefighters’ exposure to PAHs. Indeed, PAHs are electrophilic substances 
that have been associated with cardiovascular disease and adverse reproductive outcomes [86]. 
Unmetabolized PAHs are known for their teratogenic, mutagenic, and carcinogenic properties and 
therefore constitute a serious threat to the health of humans [19], [20]. Positive association between 
the urinary levels of 1OHNaph, 2OHNaph, 2OHPhen and total low molecular weight OH-PAHs 
with diabetes mellitus have also been reported in American adults [87]. Moreover, significant 
associations have been described between the levels of urinary 1OHPy with asymmetric 
dimethylarginine in the plasma and also with adipocyte-fatty acid binding protein present in the serum 
of Mexican women [27], [28]. However, the major concern is the ability of PAH reactive metabolites 
(in the form of epoxides and dihydrodiols) to bind to some proteins and DNA molecules, thus leading 
to biochemical disruptions and cell damage that may originate mutations, tumors and cancers [88]. 
Regarding the incidence of cancer in firefighters, some studies reported an elevated risk of developing 
several types of cancers, including urothelial, skin, lung, kidney and testicular cancers throughout 
their professional career; however, some findings remain contradictory [89], [90]. 
 
4. Conclusions 
This study assessed the total exposure to PAHs in three different groups of wildland firefighters 
(NSNExp, SNExp, and SExp) serving at three Portuguese fire stations through the determination of 
six urinary metabolites. SExp individuals presented levels of ∑OH-PAHs that were 355–3237% 
higher than for NSNExp subjects, with occupational exposure to fire combat activities promoting 
significant increments of 158–551% in ∑OH-PAHs. Tobacco consumption increased 76–412% the 
levels of ∑OH-PAHs for SNExp firefighters. The main findings of this research indicated that 
individual and cumulative PAHs exposure occurs by participation in firefighting activities and 
tobacco consumption. More studies concerning both occupational exposure and characterization of 
other causal factors in firefighters, as well as, toxicological and epidemiological studies are needed to 
better estimate the overall risks and the potential health effects of firefighter’s exposure to PAHs. 
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